About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
2017 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
October 2017
A Phase 1 Dose Finding Study of X4P-001 (An Oral CXCR4 Inhibitor) and Axitinib in Patients with Advanced Renal Cell Carcinoma
© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved.
Terms of Use
|
Privacy
|
Compliance and Ethics